Kiniksa Pharmaceuticals International (KNSA) News
NASDAQ: KNSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
79.78+1.03 (+1.31%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
KNSA news summary
We found 1 recent headline mentioning Kiniksa Pharmaceuticals International (KNSA): 0 in the past week and 0 in the past 30 days, most often from Nasdaq. For price context, KNSA is up 1.31% at $79.78. The most recent story, "Kymera Appoints Felix Baker As Board Chairman, Succeeds Bruce Booth", was published by Nasdaq on Jun 25, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology